Definitive Contract 75D30123C17159
Award Date
8/25/23
Potential Completion Date
8/24/26
Potential Value
$620K
Federal Agency
CDC Pittsburgh
Awardee
Genesis Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wellington, CO 80549, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced bait to control immature Ixodes scapularis ticks in rodents. The contract has a total ceiling value of $249,940.00 and a completion date of September 23, 2024. Genesis Laboratories has previously received multiple federal contracts from the CDC for vector-borne disease research...
This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced...
Genesis Laboratories, Inc. was awarded a $570,428.55 firm fixed price definitive contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide a mineral lick to systematically control black-legged ticks and reduce Lyme disease incidence among white-tailed deer populations in Wellington, Colorado. As a subchapter S corporation, Genesis Laboratories will supply mineral licks intended to deliver fipronil-laced oral bait to white-tailed deer, in...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $257,036.00 firm-fixed-price contract to the Connecticut Agricultural Experimental Station (CAES), a state government research entity, to conduct oral delivery of the acaricide (pesticide that kills ticks and mites) moxidectin to white-tailed deer populations. This effort aims to manage the vector tick Amblyomma americanum, which transmits pathogens. The contract, which has no set-aside designation, runs through September 27,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $220,000 firm fixed-price purchase order to the Connecticut Agricultural Experimental Station to conduct research on the evaluation of fall and spring acaricide (pesticide) applications to suppress host-seeking Ixodes scapularis (blacklegged) ticks. The research aims to clarify the value of fall acaricide applications in controlling Ixodes scapularis ticks on residential properties, which can...
This is a $1,315,748.75 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Banfieldbio Inc., a for-profit technology research company located in Woodinville, Washington. The contract is for research and development services related to developing novel pest management solutions and innovative technologies for pest control, with a focus on areas such as insect and tick management. The contract is not set-aside and has a period of...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation. The contract, valued at $100,000.00, is for tick management, tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide (pesticide for killing ticks) application methods. The contract has an ultimate completion date of August 20, 2018 and was awarded on August 21, 2017. The award was not...
This is a $1,103,280.60 Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Geisinger Clinic, a non-profit healthcare organization, for the "Surveillance Based Lyme Disease Network (SUBLYME)" project. The contract does not have a set-aside designation. Geisinger Clinic will provide surveillance and research services related to Lyme disease, leveraging its expertise in areas such as epidemiology, implementation science, and community...
This federal contract award was made by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Tick Box Technology Corporation, a manufacturer of goods, for the purchase of Tick Control System Master Cases - Bait Boxes. The contract, valued at $112,226.00, is a Firm Fixed Price purchase order with a completion date of June 30, 2019. The original solicitation was a pre-solicitation notice that cited the statutory authority of 10 U.S.C. 2304(c)(1)...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for a Feasibility Tick Disease Management effort. The $230,000.00 contract, which has a completion date of September 10, 2022, is focused on tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods. The contract does not have...